[Measure of quality of life in patients with metastatic colorectal cancer: techniques and main results].
OBJECTIVE
Until the 1990s, the patient's duration of life was the main measure for determining the value of palliative chemotherapy for colorectal cancer. Quality of life recently appeared as a main end point. The aim of this article is to provide an overview of the instruments used to measure quality of life in patients with metastatic colorectal cancer, to review the published data and to analyse the bias and methodological problems.


BACKGROUND
QoL is a multidimensional subjective concept, which can be measured using psychometric instruments. Quality of life measurement has a descriptive and prognostic value. Results from quality of life assessment in randomized trials have given useful information and help patients and physicians to choose between treatment options. More than half of the patients with palliative chemotherapy had at least stabilization of quality of life. Response to chemotherapy and side-effects influence quality of life. Quality of life assessment clearly requires methodological improvement. Missing data are a particularly difficult problem, which should be improved by a better organization.


CONCLUSIONS
Psychometric properties of EORTC QLQ-CR38 et FACT-C should be checked in French language. An international consensus on methods of measurement of quality of life in oncology is warranted to enhance compliance, to better interpret quality of life results et to optimize publications of precise quality of life data.
D015179:Colorectal Neoplasms / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007802:Language; D010166:Palliative Care; D010347:Patient Care Planning; D010349:Patient Compliance; D011594:Psychometrics; D011788:Quality of Life; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
Mesure de la qualité de vie des patients atteints de cancer colorectal métastatique: techniques et principaux résultats.